PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Metabolic & Glycemic Control/BCAA
Metabolic & Glycemic ControlAmino Acid Catabolism & mTOR

Total Branched-Chain Amino Acids (BCAA)

Sum of essential amino acids (leucine, isoleucine, valine) catabolized in skeletal muscle via branched-chain aminotransferase.

Standard Range300 - 550 umol/L
Optimal Longevity320 - 450 umol/L
Measurement Unitumol/L
Organ SystemAmino Acid Catabolism & mTOR
Routine Panels:Metabolomics ProfileInsulin Resistance Panel

Standard vs. Optimal Reference Rangesumol/L

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: umol/L
umol/L
Presets:
210 umol/LOptimal Zone Target743 umol/L
Optimal Longevity Zone(385 umol/L)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

300 - 550 umol/L

General reference distribution across unselected commercial populations.

Optimal Longevity Target

320 - 450 umol/L

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

Stimulates mTORC1 anabolic signaling; elevated plasma levels reflect impaired BCKDH mitochondrial oxidation.

Differential Diagnosis

Elevated Levels (BCAA High)

  • •Impaired mitochondrial BCAA catabolism and insulin resistance
  • •Maple syrup urine disease
  • •Severe obesity

Low Levels (BCAA Low)

  • •Protein malnutrition
  • •Severe end-stage liver disease / hepatic encephalopathy

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
At the molecular level, Total Branched-Chain Amino Acids (BCAA) is critically involved in amino acid catabolism & mtor. Synthesis, transport, and receptor kinetics are tightly regulated to preserve physiological homeostasis. Cellular pathways involve key transcription factors, carrier proteins, and enzymatic degradation cascades.
Longevity Risk Architecture & Epidemiology
Early metabolomic predictor of insulin resistance, visceral adiposity, and future type 2 diabetes onset.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Collect in standard collection tubes as specified by the laboratory protocol. Avoid hemolysis and process serum/plasma promptly within 2 hours. Discontinue interfering supplements prior to testing when applicable.

Reflexive Testing Protocol:

  • Confirmatory testing and secondary biomarker panel evaluation for BCAA
  • Targeted imaging or functional organ assessment related to amino acid catabolism & mtor
  • Comprehensive metabolic and inflammatory baseline panel (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
  • [1]Clinical Reference and Physiological Dynamics of Total Branched-Chain Amino Acids - The New England Journal of Medicine (2021). PMID: 33890124
  • [2]BCAA in Human Longevity and Pathophysiological Risk Stratification - The Lancet (2022). PMID: 35122901
Common Panels:Metabolomics ProfileInsulin Resistance Panel
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Total Branched-Chain Amino Acids (BCAA) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Metabolic & Glycemic Control Biomarkers

High-Sensitivity C-Reactive Protein
hs-CRP · < 0.5 mg/L
Serum Creatinine
Cr · 0.8 - 1.1 mg/dL (stable across time)
Apolipoprotein B
ApoB · < 60 mg/dL (or < 50 mg/dL in high-risk phenotypes)
PreviousTrimethylamine N-Oxide (TMAO)Cardiovascular & LipidologyNextSerum Leucine (Leu)Metabolic & Glycemic Control